» Articles » PMID: 20162412

Neurodegenerative Influence of Oxidative Stress in the Retina of a Murine Model of Diabetes

Overview
Journal Diabetologia
Specialty Endocrinology
Date 2010 Feb 18
PMID 20162412
Citations 140
Authors
Affiliations
Soon will be listed here.
Abstract

Aims/hypothesis: Diabetic retinopathy is a progressive neurodegenerative disease, but the underlying mechanism is still obscure. Here, we focused on oxidative stress in the retina, and analysed its influence on retinal neurodegeneration, using an antioxidant, lutein.

Methods: C57BL/6 mice with streptozotocin-induced diabetes were constantly fed either a lutein-supplemented diet or a control diet from the onset of diabetes, and their metabolic data were recorded. In 1-month-diabetic mice, reactive oxygen species (ROS) in the retina were measured using dihydroethidium and visual function was evaluated by electroretinograms. Levels of activated extracellular signal-regulated kinase (ERK), synaptophysin and brain-derived neurotrophic factor (BDNF) were also measured by immunoblotting in the retina of 1-month-diabetic mice. In the retinal sections of 4-month-diabetic mice, histological changes, cleaved caspase-3 and TUNEL staining were analysed.

Results: Lutein did not affect the metabolic status of the diabetic mice, but it prevented ROS generation in the retina and the visual impairment induced by diabetes. ERK activation, the subsequent synaptophysin reduction, and the BDNF depletion in the diabetic retina were all prevented by lutein. Later, in 4-month-diabetic mice, a decrease in the thickness of the inner plexiform and nuclear layers, and ganglion cell number, together with increase in cleaved caspase-3- and TUNEL-positive cells, were avoided in the retina of lutein-fed mice.

Conclusions/interpretation: The results indicated that local oxidative stress that has a neurodegenerative influence in the diabetic retina is prevented by constant intake of a lutein-supplemented diet. The antioxidant, lutein may be a potential therapeutic approach to protect visual function in diabetes.

Citing Articles

The Role of Diet and Oral Supplementation for the Management of Diabetic Retinopathy and Diabetic Macular Edema: A Narrative Review.

DAngelo A, Lixi F, Vitiello L, Gagliardi V, Pellegrino A, Giannaccare G Biomed Res Int. 2025; 2025:6654976.

PMID: 40041571 PMC: 11876532. DOI: 10.1155/bmri/6654976.


Oxidative stress and retinopathy: evidence from epidemiological studies.

Liu X, Chang Y, Li Y, Liu Y, Song W, Lu J J Transl Med. 2025; 23(1):94.

PMID: 39838377 PMC: 11748554. DOI: 10.1186/s12967-025-06110-4.


Lutein improves remyelination by reducing of neuroinflammation in C57BL/6 mouse models of multiple sclerosis.

Firozjae A, Shiran M, Ajami A, Farzin D, Rashidi M Heliyon. 2024; 10(20):e39253.

PMID: 39640747 PMC: 11620235. DOI: 10.1016/j.heliyon.2024.e39253.


Neuroprotective Effects of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors (Gliflozins) on Diabetes-Induced Neurodegeneration and Neurotoxicity: A Graphical Review.

Gholami M, Coleman-Fuller N, Salehirad M, Darbeheshti S, Motaghinejad M Int J Prev Med. 2024; 15:28.

PMID: 39239308 PMC: 11376549. DOI: 10.4103/ijpvm.ijpvm_5_23.


Metabolic memory and diabetic retinopathy: Legacy of glycemia and possible steps into future.

Sheemar A, Bellala K, Sharma S, Sharma S, Kaur I, Rani P Indian J Ophthalmol. 2024; 72(6):796-808.

PMID: 38804800 PMC: 11232859. DOI: 10.4103/IJO.IJO_2563_23.


References
1.
Snodderly D, Auran J, Delori F . The macular pigment. II. Spatial distribution in primate retinas. Invest Ophthalmol Vis Sci. 1984; 25(6):674-85. View

2.
Kurihara T, Ozawa Y, Nagai N, Shinoda K, Noda K, Imamura Y . Angiotensin II type 1 receptor signaling contributes to synaptophysin degradation and neuronal dysfunction in the diabetic retina. Diabetes. 2008; 57(8):2191-8. PMC: 2494692. DOI: 10.2337/db07-1281. View

3.
Rivero A, Mora C, Muros M, Garcia J, Herrera H, Navarro-Gonzalez J . Pathogenic perspectives for the role of inflammation in diabetic nephropathy. Clin Sci (Lond). 2009; 116(6):479-92. DOI: 10.1042/CS20080394. View

4.
Kern T, Barber A . Retinal ganglion cells in diabetes. J Physiol. 2008; 586(18):4401-8. PMC: 2614025. DOI: 10.1113/jphysiol.2008.156695. View

5.
Jin X, Ohgami K, Shiratori K, Suzuki Y, Hirano T, Koyama Y . Inhibitory effects of lutein on endotoxin-induced uveitis in Lewis rats. Invest Ophthalmol Vis Sci. 2006; 47(6):2562-8. DOI: 10.1167/iovs.05-1429. View